Causes and consequences of tumour acidity and implications for treatment

Molecular Medicine Today

Volumn 6, Issue 1, 2000, Pages 15-19

  Stubbs, Marion ^a   McSheehy, Paul M J ^a   Griffiths, John R ^a   Bashford, C Lindsay ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID;

ACIDITY; ARTICLE; CANCER CELL; CELL PH; ENZYME ACTIVITY; GLYCOLYSIS; HUMAN; METABOLIC RATE; NONHUMAN;

EID: 0033986761     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(99)01615-9     Document Type: Note

References (24)

1. Warburg O. The Metabolism Of Tumours. 1930;Arnold Constable, London.
2. 31P-NMR investigation of solid tumours in the living rat. Biosci. Rep. 1:1981;319-325.
3. Vaupel P.et al. Blood flow, Oxygen and nutrient supply, the metabolic microenvironment of human tumours: a review. Cancer Res. 49:1989;6449-6465.
4. Gillies R.J.et al. Role of intracellular pH in mammalian cell proliferation, Cell. Physiol. Biochem. 2:1992;159-179.
5. Stubbs, M. (1998) in Tumour pH, Blood perfusion and Microenvironment of Human tumours: Implications for Clinical Radio-Oncology. Diagnostic Imaging and Radiation Oncology (Molls, M. and Vaupel, P. eds), Vol. 11, pp. 113-120, Springer-Verlag, Berlin.
6. 31P-MRS measurements of extracellular pH of tumours using 3-aminopropylphosphonate. Am. J. Physiol. 267:1994;195-203.
7. Frenzel T.et al. Non-invasive in vivo measurements using a fluorinated pH probe and fluorine-19 magnetic resonance spectroscopy. Invest. Radiol. 29:1994;S220-S222.
8. Weber G. Carbohydate metabolism in cancer cells and the molecular correlation concept. Naturwissenschaften. 55:1968;418-429.
9. Davies S.E., Brindle K.M. Effects of overexpression of phosphofructokinase on glycolysis in the yeast Saccharomyces cerevisiae. Biochemistry. 31:1992;4729-4735.
10. Fell D. Snell K. Understanding the control of metabolism. Frontiers in Metabolism (No. 2). 1996;Portland Press.
11. Gleadle J.M., Ratcliffe P.J. Hypoxia and the regulation of gene expression. Mol. Med. Today. 4:1998;122-129.
12. Semenza G.L.et al. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int. 51:1997;553-555.
13. Maxwell P.H.et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
14. Stubbs M.et al. Causes and consequences of acidic pH in tumours; a magnetic resonance study. Adv. Enzyme Regul. 39:1999;13-30.
15. Newell K.et al. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumour acidity. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1127-1131.
16. Yamagata M.et al. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br. J. Cancer. 77:1998;1726-1731.
17. Folkman J. Tumour angiogenesis and tissue factor. Nat. Med. 2:1996;167-168.
18. Gatenby R.A., Gawlinski E.T. A reaction-diffusion model of cancer. Cancer Res. 56:1996;5745-5753.
19. Ivanov S.V.et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. 95:1998;12596-12601.
20. Stubbs M.et al. Metabolic consequences of a reversed pH gradient in rat tumours. Cancer Res. 54:1994;4011-4016.
21. Gerweck L.E. Tumour pH: implications for treatment and novel drug design. Semin. Radiat. Oncol. 8:1998;176-182.
22. Ojugo A.S.E.et al. Influence of pH on the uptake of 5-Fluorouracil into Lettre ascites tumour cells. Br. J. Cancer. 77:1998;873-879.
23. Yamagata M., Tannock I.F. The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects. Br. J. Cancer. 73:1996;1328-1334.
24. Vukovic V., Tannock I.F. Influence of low pH on cytotoxicity of paclitaxel, mitoxanthrone and topotecan. Br. J. Cancer. 75:1997;1167-1172.